Dr. Stephen Liu Embarks on New Journey as Chief of Hematology and Oncology at MedStar Georgetown

Introduction MedStar Health is excited to announce the appointment of Dr. Stephen Liu, MD, as the new division chief of Hematology and Oncology at MedStar Georgetown University Hospital. This position places Dr. Liu at the forefront of cancer care and research, within a facility renowned for its commitment to transformative cancer treatments. ### Dr. Liu's Background Dr. Liu's extensive background in oncology equips him for the challenges ahead. With previous successes as the director of Thoracic Oncology at Georgetown Lombardi Comprehensive Cancer Center, he has gained both national and international acclaim for his work on clinical trials targeting advanced lung cancer therapies. His impressive portfolio includes a wealth of publications in prestigious medical journals, such as the New England Journal of Medicine and Lancet. Furthermore, Dr. Liu is also involved in public engagement through his role as a co-host for the podcast affiliated with the International Association for the Study of Lung Cancer (IASLC). ### Role of MedStar Georgetown MedStar Georgetown University Hospital is part of the MedStar Georgetown Cancer Institute and is distinguished by its multidisciplinary approach to cancer treatment. The institute is recognized for providing comprehensive services, ranging from screening and prevention to treatment and survivorship programs. Dr. Liu’s leadership will enhance the institute's mission to offer the most advanced therapies and cutting-edge research opportunities to patients. ### Commitment to Patient Care In his new position, Dr. Liu is focused on ensuring that all cancer patients receive high-quality care tailored to their specific needs. His vision extends beyond immediate treatment; he aims to foster an environment where patients can access clinical trials that could lead to breakthroughs in cancer therapy. "I am honored and humbled to accept this new role as chief of Hematology and Oncology at MedStar Georgetown," says Dr. Liu, highlighting his eagerness to collaborate with esteemed colleagues. ### Innovative Research Initiatives Under Dr. Liu's direction, the division will likely explore new avenues in cancer research, pushing the envelope of what is possible in the oncological field. As a leader who has pioneered novel therapy approaches, he intends to cultivate a culture of inquiry and excellence among the team at MedStar Georgetown. This entails implementing patient-centric research protocols that prioritize the needs and health outcomes of those battling cancer. ### The Importance of Collaboration What sets MedStar Georgetown apart is its collaborative environment where various specialists work in tandem to ensure comprehensive care for each patient. As Dr. Liu steps into his role, he will emphasize the significance of teamwork, leveraging the expertise of professionals across different oncology specializations. This approach is vital in tackling complex cancer cases, where a single solution is rarely sufficient. ### Conclusion With Dr. Stephen Liu at the helm of Hematology and Oncology, MedStar Georgetown University Hospital is poised for exciting advancements in both clinical and research realms. His commitment to delivering high-quality patient care, coupled with a vision for pioneering research, aligns perfectly with MedStar’s mission to transform cancer treatment. The coming years promise to hold significant developments in cancer care, thanks to Dr. Liu's leadership and dedication to innovation.